BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8044304)

  • 1. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis.
    Hoshii Y; Takahashi M; Ishihara T; Uchino F
    Pathol Int; 1994 May; 44(5):352-8. PubMed ID: 8044304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.
    Strege RJ; Saeger W; Linke RP
    Virchows Arch; 1998 Jul; 433(1):19-27. PubMed ID: 9692821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein.
    Tada S; Iida M; Yao T; Kawakubo K; Yao T; Okada M; Fujishima M
    Gastrointest Endosc; 1994; 40(1):45-50. PubMed ID: 8163134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.
    Tateishi Y; Yamada Y; Katsuki M; Nagata T; Yamamoto H; Kohashi K; Koga Y; Hashisako M; Kiyozawa D; Mori T; Kuboyama Y; Kakinokizono A; Miyazaki Y; Yamaguchi A; Tsutsui H; Ninomiya T; Naiki H; Oda Y
    Pathol Res Pract; 2021 Nov; 227():153635. PubMed ID: 34653913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
    Honda K; Hara M; Ogura Y; Nihei H; Mimura N
    Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.
    Laeng RH; Altermatt HJ; Scheithauer BW; Zimmermann DR
    Cancer; 1998 Jan; 82(2):362-74. PubMed ID: 9445195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of amyloid lymphadenopathy in uremic patients.
    Güz G; Ozdemir BH; Sezer S; Yakupoglu U; Demirhan B; Ozdemir FN; Haberal M
    Ren Fail; 2000; 22(5):613-21. PubMed ID: 11041293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral organ involvement and extracellular matrix changes in beta 2-microglobulin amyloidosis--a comparative study with systemic AA and AL amyloidosis.
    Ohashi K; Takagawa R; Hara M
    Virchows Arch; 1997 Jun; 430(6):479-87. PubMed ID: 9230913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
    Shirahama T; Skinner M; Cohen AS; Gejyo F; Arakawa M; Suzuki M; Hirasawa Y
    Lab Invest; 1985 Dec; 53(6):705-9. PubMed ID: 2415776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular involvement in systemic AA and AL amyloidosis: a clear haematogenic pattern.
    Schröder R; Linke RP
    Virchows Arch; 1999 Jun; 434(6):551-60. PubMed ID: 10394892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple histological method differentiating AL-type from AA-type amyloidosis.
    Horita S; Nitta K; Honda K; Yumura W; Nihei H
    Nephron; 1998; 78(2):240-2. PubMed ID: 9496753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.